CO6210821A2 - Metodo para la produccion de clorhidrato de prasugrel de lata pureza - Google Patents

Metodo para la produccion de clorhidrato de prasugrel de lata pureza

Info

Publication number
CO6210821A2
CO6210821A2 CO09093300A CO09093300A CO6210821A2 CO 6210821 A2 CO6210821 A2 CO 6210821A2 CO 09093300 A CO09093300 A CO 09093300A CO 09093300 A CO09093300 A CO 09093300A CO 6210821 A2 CO6210821 A2 CO 6210821A2
Authority
CO
Colombia
Prior art keywords
compound represented
formula
solvent
prasugrel
hydraulate
Prior art date
Application number
CO09093300A
Other languages
English (en)
Inventor
Hiroyuki Miyata
Yukinori Wada
Naoyuki Yokota
Original Assignee
Daiichi Sankyo Co Ltd
Ube Ind Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39738173&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6210821(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daiichi Sankyo Co Ltd, Ube Ind Ltda filed Critical Daiichi Sankyo Co Ltd
Publication of CO6210821A2 publication Critical patent/CO6210821A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

1.- Un método para producir un clorhidrato de prasugrel, que comprende las etapas de: (i) cloración de un compuesto representado por la fórmula:al agregar un agente de cloración opcionalmente a gotas a este en un solvente; (ii) reacción del compuesto resultante representado por la fórmula:con un compuesto representado por la fórmula general:en donde R representa un grupo protector para un grupo hidroxilo, o una sal del mismo en un solvente en presencia de una base; (iii) acetilación del compuesto resultante representado por la fórmula general:en donde R tiene el mismo significado al dado anteriormente, mediante la reacción de un agente de acetilación con este en un solvente en presencia de una base y un catalizador de acilación; y (iv) la adición de ácido clorhídrico, opcionalmente a gotas, al compuesto resultante representado por la fórmula:
CO09093300A 2007-03-02 2009-09-02 Metodo para la produccion de clorhidrato de prasugrel de lata pureza CO6210821A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007053093 2007-03-02

Publications (1)

Publication Number Publication Date
CO6210821A2 true CO6210821A2 (es) 2010-10-20

Family

ID=39738173

Family Applications (1)

Application Number Title Priority Date Filing Date
CO09093300A CO6210821A2 (es) 2007-03-02 2009-09-02 Metodo para la produccion de clorhidrato de prasugrel de lata pureza

Country Status (25)

Country Link
US (2) US20100094013A1 (es)
EP (1) EP2123656B1 (es)
JP (1) JP5363307B2 (es)
KR (1) KR101505212B1 (es)
CN (2) CN101675058A (es)
AU (1) AU2008222000B2 (es)
BR (1) BRPI0808034A2 (es)
CA (1) CA2679925C (es)
CO (1) CO6210821A2 (es)
CY (1) CY1115518T1 (es)
DK (1) DK2123656T3 (es)
ES (1) ES2487190T3 (es)
HK (1) HK1136278A1 (es)
HR (1) HRP20140668T1 (es)
IL (1) IL200647A (es)
MX (1) MX2009009413A (es)
MY (1) MY151726A (es)
NZ (1) NZ579993A (es)
PL (1) PL2123656T3 (es)
PT (1) PT2123656E (es)
RU (1) RU2435776C2 (es)
SI (1) SI2123656T1 (es)
TW (1) TWI417295B (es)
WO (1) WO2008108291A1 (es)
ZA (1) ZA200906850B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009011619A (es) 2007-04-27 2010-01-18 Cydex Pharmaceuticals Inc Formulaciones que contienen clopidogrel y eter sulfoalquilico-ciclodextrina y metodos de uso.
US20100261908A1 (en) * 2007-11-09 2010-10-14 Dr. Reddy's Laboratories Ltd. Processes for the preparation of prasugrel , and its salts and polymorphs
CN101684124B (zh) * 2008-09-22 2013-11-13 广州赫尔氏药物开发有限公司 新的具有抗凝血作用的化合物
CN103936756B (zh) * 2008-09-22 2017-09-19 广州赫尔氏药物开发有限公司 具有抗凝血作用的化合物
CN101486635B (zh) * 2009-02-27 2012-10-10 上海医药工业研究院 α-环丙基羰基-2-氟苄基卤素的制备方法
WO2010132711A1 (en) 2009-05-13 2010-11-18 Cydex Pharmaceuticals, Inc. Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
CN101993447A (zh) * 2009-08-26 2011-03-30 浙江华海药业股份有限公司 一种人工合成普拉格雷的方法
HU229031B1 (en) 2009-12-21 2013-07-29 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Process for producing prasurgel and its intermediate
HU229035B1 (en) 2009-12-21 2013-07-29 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Process for producing prasurgel
CN101735241A (zh) * 2009-12-24 2010-06-16 浙江普洛家园药业有限公司 普拉格雷中间体及其制备方法
CN102869668A (zh) 2010-03-09 2013-01-09 斯索恩有限公司 制备普拉格雷的方法
US20130053569A1 (en) * 2010-03-23 2013-02-28 Jayaraman Venkat Raman Process for the preparation of prasugrel hcl salt
WO2012001486A1 (en) * 2010-06-28 2012-01-05 Mayuka Labs Pvt. Ltd. An improved process for the preparation of prasugrel hydrochloride and its intermediates
WO2012018791A2 (en) * 2010-08-06 2012-02-09 Dr. Reddy's Laboratories Ltd. Preparation of prasugrel hydrochloride
CN101948479B (zh) * 2010-09-29 2013-01-30 横店集团家园化工有限公司 普拉格雷中间体及其制备方法
HUP1000565A2 (en) 2010-10-22 2012-05-02 Egis Gyogyszergyar Nyrt Process for the preparation of pharmaceutically active compound and intermediers
CN102101827B (zh) * 2010-11-15 2013-07-03 山东新华制药股份有限公司 一种普拉格雷中间体α-环丙羰基-2-氟苄基卤的制备方法
US9556196B2 (en) 2011-04-14 2017-01-31 Guangzhou Heershi Pharma Development Co., Ltd Anti-platelet compound addition salt
CN102746318A (zh) * 2011-04-20 2012-10-24 上海信谊药厂有限公司 用于制备普拉格雷盐酸盐的方法
CN102276623A (zh) * 2011-06-13 2011-12-14 安徽省虹升生物科技有限公司 一种利用有机硅保护剂进行制备普拉格雷的新方法
CN102838618A (zh) 2011-06-22 2012-12-26 广东东阳光药业有限公司 一种制备普拉格雷的方法及普拉格雷盐酸盐新晶型
WO2013024399A1 (en) * 2011-08-12 2013-02-21 Alembic Pharmaceuticals Limited Improved method for quantitative determination of prasugrel hydrochloride
CN102977115B (zh) * 2012-11-16 2015-01-21 江苏先声药业有限公司 普拉格雷游离碱的合成新方法
CN105085541A (zh) * 2014-05-07 2015-11-25 江苏先声药业有限公司 一种普拉格雷类似物的制备方法
HU231079B1 (hu) 2016-06-23 2020-06-29 Richter Gedeon Nyrt. Eljárás nagytisztaságú Prasugrel előállítására bromopentil szennyezés eltávolításával
CN112047959A (zh) * 2020-10-21 2020-12-08 深圳市祥根生物科技有限公司 一种普拉格雷开环氯代杂质的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI101150B (fi) * 1991-09-09 1998-04-30 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi
JP3840662B2 (ja) * 1994-10-07 2006-11-01 宇部興産株式会社 ２−シリルオキシ−テトラヒドロチエノピリジン類、その塩およびその製造方法
WO2002004461A1 (fr) * 2000-07-06 2002-01-17 Sankyo Company, Limited Sels d'addition acides de dérivés hydropyridine
JP4001199B2 (ja) * 2000-07-06 2007-10-31 第一三共株式会社 ヒドロピリジン誘導体酸付加塩
PT1350511E (pt) * 2000-12-25 2008-10-28 Ube Industries Composições medicinais contendo aspirina
JP4029974B2 (ja) * 2001-12-21 2008-01-09 第一三共株式会社 ヒドロピリジン誘導体酸付加塩を含有する医薬
JP2006525328A (ja) * 2003-05-05 2006-11-09 イーライ リリー アンド カンパニー 心疾患の治療方法
TWI318571B (en) * 2005-06-10 2009-12-21 Lilly Co Eli Formulation of a thienopyridine platelet aggregation inhibitor
TWI392681B (zh) * 2006-04-06 2013-04-11 Daiichi Sankyo Co Ltd 高純度普拉格雷及其酸加成鹽之製法

Also Published As

Publication number Publication date
HRP20140668T1 (hr) 2014-10-10
CN101675058A (zh) 2010-03-17
US20130345428A1 (en) 2013-12-26
CN102424686A (zh) 2012-04-25
MY151726A (en) 2014-06-30
JPWO2008108291A1 (ja) 2010-06-17
PL2123656T3 (pl) 2014-11-28
ZA200906850B (en) 2010-06-30
IL200647A (en) 2015-02-26
KR101505212B1 (ko) 2015-03-23
AU2008222000B2 (en) 2012-06-14
PT2123656E (pt) 2014-09-08
NZ579993A (en) 2012-06-29
WO2008108291A1 (ja) 2008-09-12
HK1136278A1 (en) 2010-06-25
US20100094013A1 (en) 2010-04-15
CA2679925C (en) 2012-10-02
KR20090127267A (ko) 2009-12-10
SI2123656T1 (sl) 2014-09-30
BRPI0808034A2 (pt) 2014-06-17
RU2009136445A (ru) 2011-04-10
JP5363307B2 (ja) 2013-12-11
RU2435776C2 (ru) 2011-12-10
CA2679925A1 (en) 2008-09-12
EP2123656B1 (en) 2014-06-11
EP2123656A4 (en) 2011-05-04
CY1115518T1 (el) 2017-01-04
ES2487190T3 (es) 2014-08-20
DK2123656T3 (da) 2014-09-08
TW200844104A (en) 2008-11-16
MX2009009413A (es) 2009-09-11
TWI417295B (zh) 2013-12-01
IL200647A0 (en) 2010-05-17
EP2123656A1 (en) 2009-11-25
AU2008222000A1 (en) 2008-09-12

Similar Documents

Publication Publication Date Title
CO6210821A2 (es) Metodo para la produccion de clorhidrato de prasugrel de lata pureza
BRPI0415855A (pt) processo para preparação de ésteres de ácido 2-dihalogenacil-3-amino-acrìlico e ésteres de ácido 3-dihalogeno-metil-pirazol-4-carboxìlico
ECSP10010526A (es) Compuesto heterociclico
AR076027A1 (es) Metodos e intermediarios para la preparacion de agentes farmaceuticos
BRPI0615705A2 (pt) processo para preparar um composto, e, composto
CO6140036A2 (es) Metodo para producir prasugrel de alta pureza o una sal acida de adicion del mismo
GT200300296A (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
ATE440094T1 (de) Fumagillolderivate und verfahren zu deren herstellung
UY32259A (es) Nuevos compuestos de hidroxiareno, preparados farmaceuticos que los contienen y aplicaciones
CO6351739A2 (es) Nuevos compuestos quimicos
TW200738692A (en) New substituted glycinamides, process for their manufacture and use thereof as medicaments
ATE441630T1 (de) Substituierte cyclopenten-verbindungen
CR9221A (es) Procesos para preparar eteres aromaticos
AR051667A1 (es) Uso de polisilazanos para recubrir tiras metalicas
NO20075385L (no) 7-aminoalkylidenyl-heterocykliske kinoloner og naftyridoner
NO20073839L (no) Kinolinderivat, fremgangsmate for fremstilling og anvendelse av dette, og legemiddel inneholdende dette
GT200500338A (es) Nuevos inhibidores de hmg co-a reductasa basados en pirazol
PA8579901A1 (es) Bifenilcarboxamidas sustituidas con n-aril piperidina
GT200600208A (es) Compuestos organicos
TW200740798A (en) Substituted amides, process for their manufacture and use thereof as medicaments
AR070737A1 (es) Proceso para la elaboracion de (fenilsulfanilfenil) piperidinas
AR056807A1 (es) Proceso para la produccion de carboxanilidas
GT200600104A (es) Proceso para la purificacion de compuestos benzoxazol substituidos
ATE517890T1 (de) Verfahren zur herstellung von reinem irbesartan
ATE458721T1 (de) Iminosäurederivate als inhibitoren von matrix- metalloproteinasen

Legal Events

Date Code Title Description
FC Application refused